Skip to Content
Merck
CN

345789

FluorSave Reagent

Synonym(s):

mounting medium

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.75
UNSPSC Code:
41116133
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

liquid

Quality Level

contains

≤0.1% sodium azide as preservative

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

shipped in

ambient

storage temp.

10-30°C

General description

An aqueous mounting medium for use in conjunction with fluorescent tracers such as fluorescein, rhodamine and phycobiliprotein probes. Specifically designed for preserving fluorescent stained tissue sections. FluorSave is formulated without glycerol and therefore is ideal for use with phycobiliproteins.
Aqueous mounting medium for use in conjunction with fluorescent tracers such as fluorescein, rhodamine, and phycobiliprotein probes. Preserves fluorescence-stained tissue sections. Specially formulated without glycerol. Ideal for use with phycobiliprotein tracers.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)


Storage Class

10 - Combustible liquids



Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Srinidhi Jayaraman et al.
Journal of neurochemistry, 153(1), 120-137 (2019-09-06)
Previous studies documented up-regulation of peptidase neurolysin (Nln) after brain ischemia, however, the significance of Nln function in the post-stroke brain remained unknown. The aim of this study was to assess the functional role of Nln in the brain after
Sivakumar Vijayaraghavalu et al.
Biomaterials, 227, 119558-119558 (2019-10-28)
Advanced-stage cancers often metastasize to bone, and is the major cause of cancer-related morbidity and mortality. Due to poor biodistribution of intravenously administered anticancer drugs within the bone, chemotherapy is not optimally effective in treating bone metastasis. Additionally, overexpression of
Frederik Walter et al.
PloS one, 15(9), e0239369-e0239369 (2020-10-01)
Cancer vaccinations sensitize the immune system to recognize tumor-specific antigens de novo or boosting preexisting immune responses. Dendritic cells (DCs) are regarded as the most potent antigen presenting cells (APCs) for induction of (cancer) antigen-specific CD8+ T cell responses. Chitosan



Global Trade Item Number

SKUGTIN
345789-20ML07790788049324